AI Airlock Phase 2 application
Candidates can now apply to the Medicines and Healthcare products Regulatory Agency (MHRA) to join the AI Airlock phase 2.
This application process is designed to gather information about AI Medical Devices (AIaMD) and prototypes and evaluate their suitability for the AI Airlock sandbox. We are looking to recruit up to 4 candidates to form the next cohort that cover a wide range of regulatory issues, healthcare or clinical disciplines and levels of product and regulatory development.
During the Airlock programme candidates will benefit from a unique collaboration of industry and regulatory experts, a bespoke testing plan and gain an improved understanding of the current regulatory framework. Participation in the regulatory sandbox presents an opportunity for a proactive approach to AIaMD regulation, derisk the innovative products ahead of entering the market and may benefit candidate’s future routes to market.
Outputs of the Airlock programme will include project reports from each candidate team, an Airlock Sandbox report of learnings to inform future guidance and implications for the regulatory framework, and a programme evaluation report sharing learnings on the use of regulatory sandboxes.